Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shanghai Sanyou Medical Co., Ltd.
  6. News
  7. Summary
    688085   CNE1000040J7

SHANGHAI SANYOU MEDICAL CO., LTD.

(688085)
  Report
End-of-day quote Shanghai Stock Exchange  -  2022-09-29
29.91 CNY   -0.96%
08/22Shanghai Sanyou Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
06/29Implanet Announces A Commercial, Technological and Financial Partnership with Sanyou Medical
CI
04/25Shanghai Sanyou Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Implanet Announces A Commercial, Technological and Financial Partnership with Sanyou Medical

06/29/2022 | 11:45am EDT

IMPLANET announced the signing of an agreement defining the principles of a strategic, technological and financial partnership project with Sanyou Medical, a Chinese manufacturer of medical devices for spine surgery. This is also a technological partnership. The two companies will draw on their know-how and R&D to develop a brand-new comprehensive hybrid fixation range and incorporating the very latest developments and innovations in the field of spine surgery (deformation treatment system, minimally invasive range, robotics, artificial intelligence, etc.).


© S&P Capital IQ 2022
Stocks mentioned in the article
ChangeLast1st jan.
IMPLANET SA -3.12% 0.18 Real-time Quote.-41.46%
SHANGHAI SANYOU MEDICAL CO., LTD. -0.96% 29.91 End-of-day quote.6.58%
All news about SHANGHAI SANYOU MEDICAL CO., LTD.
08/22Shanghai Sanyou Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June..
CI
06/29Implanet Announces A Commercial, Technological and Financial Partnership with Sanyou Me..
CI
04/25Shanghai Sanyou Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended ..
CI
02/24Sanyou Wins China Distribution Rights for Bone Fillers From South Korea's CGBio
MT
02/21Shanghai Sanyou Medical Co., Ltd. Reports Earnings Results for the Full Year Ended Dece..
CI
2021Shanghai Sanyou Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended Se..
CI
2021Shanghai Sanyou Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June..
CI
2021Shanghai Sanyou Medical Co., Ltd. signed an agreement acquire 49.8% stake in Beijing Sh..
CI
2021Shanghai Sanyou Medical Plans to Buy Stake in Medical Technology Unit for 342.7 Mln Yua..
CI
2021Shanghai Sanyou Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended ..
CI
More news
Financials
Sales 2022 755 M 106 M 106 M
Net income 2022 218 M 30,6 M 30,6 M
Net Debt 2022 - - -
P/E ratio 2022 31,9x
Yield 2022 -
Capitalization 6 756 M 950 M 950 M
Capi. / Sales 2022 8,95x
Capi. / Sales 2023 7,00x
Nbr of Employees 442
Free-Float 31,4%
Chart SHANGHAI SANYOU MEDICAL CO., LTD.
Duration : Period :
Shanghai Sanyou Medical Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHANGHAI SANYOU MEDICAL CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 29,91
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Nong Xu General Manager & Director
Min Hui Yang Chief Financial Officer
Ming Yan Liu Chairman & Chief Scientist
Yu Li Ma Chairman-Supervisory Board
Chong Jun Ren Director & Director-Operations
Sector and Competitors
1st jan.Capi. (M$)
SHANGHAI SANYOU MEDICAL CO., LTD.6.58%950
SHOCKWAVE MEDICAL, INC.55.93%9 990
NOVOCURE LIMITED2.62%7 958
MASIMO CORPORATION-51.79%7 415
PENUMBRA, INC.-33.24%7 184
GETINGE AB-52.85%4 702